Keyphrases
Prognostic Biomarker
100%
RASSF1A
100%
Pediatric Rhabdomyosarcoma
100%
Cell-free DNA (cfDNA)
100%
Diagnostic Biomarker
100%
Tumor
50%
Rhabdomyosarcoma
40%
Event-free Survival
30%
Cell-free
30%
Reduced Representation Bisulfite Sequencing
30%
Working Diagnosis
20%
Poor Outcome
20%
Bone Marrow
20%
Diagnostic Potential
20%
Shallow Whole Genome Sequencing (sWGS)
20%
Excellent Outcome
10%
Metastatic Disease
10%
Initial Diagnosis
10%
Survival Rate
10%
Genetic Aberrations
10%
EPS-SG
10%
Pediatric Patients
10%
Plasma Samples
10%
Droplet Digital PCR (ddPCR)
10%
Clinical Application
10%
Plasma Diagnostics
10%
Survival Analysis
10%
Paired Analysis
10%
Total Cell-free DNA
10%
Prognostic Effect
10%
Prognostic Potential
10%
Double Positive
10%
Fraction Analysis
10%
Medicine and Dentistry
Pediatrics
100%
Biological Marker
100%
Diagnosis
100%
Rhabdomyosarcoma
100%
Cell-Free DNA
100%
Neoplasm
83%
Event Free Survival
50%
Reduced Representation Bisulfite Sequencing
50%
Whole Genome Sequencing
33%
Metastatic Carcinoma
16%
Survival Rate
16%
Pediatrics Patient
16%
Survival Analysis
16%
Droplet Digital Polymerase Chain Reaction
16%
Biochemistry, Genetics and Molecular Biology
RNA
100%
Event Free Survival
100%
Reduced Representation Bisulfite Sequencing
100%
Whole Genome Sequencing
66%
Blood Plasma
66%
Genetics
33%
Survival Rate
33%
Droplet Digital Polymerase Chain Reaction
33%
Immunology and Microbiology
Event Free Survival
100%
Prognostic Biomarker
100%
Whole Genome Sequencing
66%
Blood Plasma
66%
Survival Rate
33%
Droplet Digital Polymerase Chain Reaction
33%